M-A | Cognitive and neuropsychiatric effects of noradrenergic treatment in Alzheimer’s disease. 7 Jul, 2022 | 12:34h | UTC Cognitive and neuropsychiatric effects of noradrenergic treatment in Alzheimer’s disease: systematic review and meta-analysis – Journal of Neurology Neurosurgery & Psychiatry Commentaries: Expert reaction to systematic review and meta-analysis looking at the evidence of whether noradrenergic drugs may be able to treat symptoms of Alzheimer’s disease – Science Media Centre Noradrenergic drugs could be repurposed to offer effective treatment for Alzheimer’s disease symptoms – BMJ / News Medical